Effects of predictive genetic testing
Recruiting
- Conditions
- Genetic risk testing for malignancies (e.g., Breast Cancer 1/2), cardiovascular diseases, coagulation (e.g., thrombophilia), storage disorders (e.g., hemochromatosis), cholesterol, glaucoma, and pharmacogenomic information
- Registration Number
- DRKS00017820
- Lead Sponsor
- Robert Bosch Krankenhaus
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 800
Inclusion Criteria
Declaration of consent to participate in this study
- genetic testing performed
Exclusion Criteria
- current pregnancy
- Active cancer
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quality of life, recorded by means of the SF-36 questionnaire at survey times 0 (=baseline, with consent before notification of results of genetic screening), 3 months, 3 years, 5 years (if necessary 10 years) after testing
- Secondary Outcome Measures
Name Time Method